Inhibition of platelet aggregation (Update 2023)

被引：0

作者：

Wascher, Thomas C. M. ^{[1
]}

Stulnig, Thomas M. H. ^{[2
,3
]}

Saely, Christoph H. ^{[4
,5
]}

Stechemesser, Lars ^{[6
]}

机构：

[1] Hanuschkrankenhaus, Med Abt 1, Vienna, Austria

[2] Klin Hietzing, Med Abt 3, Vienna, Austria

[3] Klin Hietzing, Karl Landsteiner Inst Stoffwechselerkrankungen & N, Vienna, Austria

[4] VIVIT Inst, Abt Innere Med 1, Akadem Lehrkrankenhaus Feldkirch, Feldkirch, Austria

[5] Private Univ Furstentum Liechtenstein, Triesen, Liechtenstein

[6] Paracelsus Med Privatuniv, Univ Klin Innere Med 1, Mullner Hauptstr 48, A-5020 Salzburg, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2023年 / 135卷 / SUPPL 1期

关键词：

Platelets anti platelet drugs; Acute atherothrombosis; Diabetes mellitus; COLLABORATIVE METAANALYSIS; PRIMARY PREVENTION; ASPIRIN; EVENTS;

D O I：

10.1007/s00508-023-02168-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Acute thrombotic complications as a key feature of accelerated atherothrombotic disease typically precipitate cardiovascular events and therefore strongly contribute to cardiovascular morbidity and mortality in patients with diabetes. Inhibition of platelet aggregation can reduce the risk for acute atherothrombosis. The present article represents the recommendations of the Austrian Diabetes Association for the use of antiplatelet drugs in patients with diabetes according to current scientific evidence.

引用

页码：161 / 163

页数：3

共 50 条

[21] DIPYRIDAMOLE POTENTIATES THE INHIBITION OF PLATELET-AGGREGATION BY ASPIRIN (IN HUMAN PLATELET RICH PLASMA AND WHOLE-BLOOD)
VIOLI, F
PRATICO, D
IULIANO, L
BALSANO, F
JOURNAL OF LIPID MEDIATORS, 1991, 4 (01): : 61 - 68
[22] Aspirin Reduces the Potentiating Effect of CD40L on Platelet Aggregation via Inhibition of Myosin Light Chain
Kojok, Kevin
Mohsen, Mira
El Kadiry, Abed El Hakim
Mourad, Walid
Merhi, Yahye
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (03):
[23] Platelet aggregation pathway
Sangkuhl, Katrin
Shuldiner, Alan R.
Klein, Teri E.
Altman, Russ B.
PHARMACOGENETICS AND GENOMICS, 2011, 21 (08) : 516 - 521
[24] Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation
Kuliopulos, A
Mohanlal, R
Covic, L
THROMBOSIS AND HAEMOSTASIS, 2004, 92 (06) : 1387 - 1393
[25] Suboptimal Inhibition of Platelet Cyclooxygenase-1 by Aspirin in Metabolic Syndrome
Smith, James P.
Haddad, Elias V.
Taylor, Mary B.
Oram, Denise
Blakemore, Dana
Chen, Qingxia
Boutaud, Olivier
Oates, John A.
HYPERTENSION, 2012, 59 (03) : 719 - U405
[26] Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease
Grove, E. L.
Hvas, A. M.
Mortensen, S. B.
Larsen, S. B.
Kristensen, S. D.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (01) : 185 - 191
[27] Diabetes and migration (update 2023)
Aydinkoc-Tuzcu, Kadriye
Sat, Sebahat
Berger, Faize
Barakat, Alain
Danquah, Ina
Schindler, Karin
Fasching, Peter
WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 1) : 286 - 306
[28] ACTION OF SOME SALICYLATE DERIVATIVES ON INVITRO PLATELET-AGGREGATION - INHIBITORY AND INHIBITION ANTAGONISTIC EFFECTS
CASADEBAIG, F
DUPIN, JP
GRAVIER, D
HOU, G
DARET, D
BERNARD, H
LARRUE, J
BOISSEAU, M
THROMBOSIS RESEARCH, 1991, 64 (06) : 631 - 636
[29] Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: An integrated analysis
Weerakkody, Govinda J.
Jakubowski, Joseph A.
Brandt, John T.
Payne, Christopher D.
Naganuma, Hideo
Winters, Kenneth J.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 12 (03) : 205 - 212
[30] INHIBITION OF CYCLOOXYGENASE-INDEPENDENT PLATELET-AGGREGATION BY LOW VITAMIN-E CONCENTRATION
VIOLI, F
PRATICO, D
GHISELLI, A
ALESSANDRI, C
IULIANO, L
CORDOVA, C
BALSANO, F
ATHEROSCLEROSIS, 1990, 82 (03) : 247 - 252

← 1 2 3 4 5 →